Sanofi-Aventis, Genzyme Are on the Brink of a Merger

It seems that months of merger talks between French pharma Sanofi-Aventis and U.S. biotech Genzyme have entered the home stretch. This week, Sanofi is expected to offer $74 a share for Genzyme, with an option included potential…

Fiat May Raise Its Stake in Chrysler to 51%

Fiat CEO Sergio Marchionne said Monday that he could increase Fiat’s ownership in Chrysler to more than 50% should America’s smallest domestic automaker seek to return to the stock market this year, but that he doesn’t plan to …